Clinical trial Recruiting at 1 site Observational Ages 18 and up

GelPOINT Path-assisted endoscopic removal of colorectal polyps

Official title: GelPOINT® Path-Assisted Endoscopic Submucosal Dissection for Colorectal Polyps: A Feasibility and Safety Study

Run by Baylor College of Medicine · NCT07723937 · Data updated 2026-11-12

This study tests whether using the GelPOINT Path access platform during endoscopic submucosal dissection can safely help remove colorectal polyps in adults.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorBaylor College of Medicine
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedMay 19, 2026
Main results expectedMarch 25, 2027
Study endsApril 30, 2027
Registry record updatedJuly 23, 2026
Trial IDNCT07723937 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older with eligible colorectal polyps located in the transverse/descending colon, rectosigmoid, or rectum and referred for ESD, including larger or scarred lesions.

Probably not a fit

Patients whose polyps are not technically challenging or whose anatomy precludes GelPOINT Path use may not experience additional benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational study evaluating the feasibility and safety of GelPOINT Path-assisted endoscopic submucosal dissection (ESD) for colorectal polyps. Adult patients undergoing ESD for eligible lesions will be enrolled and treated by experienced endoscopists as part of routine care. Outcomes will include technical feasibility, procedural performance, resection results, and any procedure-related adverse events, with follow-up around 4 weeks for delayed events. Data will be collected prospectively using standardized forms to assess whether the platform improves access, visualization, and stability during distal colon and rectal procedures without altering standard management. Approximately 30 patients are planned for enrollment at Baylor College of Medicine in Houston, TX.

Why it matters

Potential benefit: If successful, the approach could make complex colorectal polyp removal safer and more efficient for patients undergoing ESD.

How similar studies have gone: Prior TAMIS-use of GelPOINT Path has shown benefits in access and visualization, but its application to colorectal ESD is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older.
* Able and willing to provide written informed consent.
* Colorectal polyps located in the transverse colon, descending colon, rectosigmoid colon, or rectum (rectal lesions located at least 2 cm from the anal verge).
* Referred for endoscopic submucosal dissection (ESD) of colorectal neoplastic lesions meeting at least one of the following criteria:
* Lesions with prior resection or scarring proximal to the sigmoid colon.
* Granular lateral spreading tumors (GLST) \>30 mm.
* Non-granular lateral spreading tumors (NGLST) \>20 mm.
* Lesions with suspected submucosal invasion, including Paris classification IIa+IIc lesions or lesions with a positive non-lifting sign

Exclusion Criteria:

* Younger than 18 years of age.
* Unable or unwilling to provide informed consent.
* Pregnant.
* Pedunculated lesions (Paris classification Ip or Isp).
* Lesions involving the appendix or ileocecal valve

Where it's running

  • Baylor College of Medicine
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.